Aptevo Therapeutics Inc (APVO)

• $0.21

  $0.43

  $0.25
  

  14.32%

  Downside

  Day's Volatility :49.62%

  Upside

  41.2%

  
• $0.14

  $15.39

  $0.25
  

  44.8%

  Downside

  52 Weeks Volatility :99.1%

  Upside

  98.38%

  

Returns

What analysts predicted

Upside of 3600.0%

• Armistice Capital, LLC

  7.95%

• Sabby Management LLC

  5.32%

• Hudson Bay Capital Management LP

  5.31%

• UBS Group AG

  1.23%

• HRT FINANCIAL LLC

  0.32%

• Baader Bank INC

  0.21%

aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. as a result, aptevo has been able to attract some of the most innovative minds in the field. many of our team members have notable experience with other pioneering biotech companies including trubion, zymogenetics, immunex, dendreon, and vlst. at aptevo therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning aptevo therapeutics to develop the science of what’s next in biotechnology.